Neurogene (NGNE) News Today $18.42 -0.55 (-2.90%) Closing price 06/17/2025 04:00 PM EasternExtended Trading$18.42 -0.01 (-0.03%) As of 06/17/2025 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NGNE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Neurogene (NASDAQ:NGNE) Coverage Initiated at Craig HallumCraig Hallum started coverage on shares of Neurogene in a research report on Tuesday. They set a "buy" rating and a $50.00 price objective for the company.June 17 at 8:43 AM | marketbeat.comNeurogene (NGNE) Gets a Buy from BMO CapitalJune 14, 2025 | theglobeandmail.comNeurogene (NGNE) Gets a Buy from TD CowenJune 14, 2025 | theglobeandmail.comNeurogene price target raised to $26 from $22 at BMO CapitalJune 13, 2025 | investing.comBMO Capital Markets Issues Positive Forecast for Neurogene (NASDAQ:NGNE) Stock PriceJune 13, 2025 | americanbankingnews.comNeurogene Inc. (NASDAQ:NGNE) Given Average Rating of "Moderate Buy" by AnalystsJune 13, 2025 | americanbankingnews.comNeurogene (NASDAQ:NGNE) Given New $26.00 Price Target at BMO Capital MarketsBMO Capital Markets boosted their price target on shares of Neurogene from $22.00 to $26.00 and gave the stock an "outperform" rating in a research report on Thursday.June 12, 2025 | marketbeat.comL’objectif de prix de Neurogene relevé à 26€ contre 22€ par BMO CapitalJune 11, 2025 | fr.investing.comTwo Sigma Investments LP Invests $472,000 in Neurogene Inc. (NASDAQ:NGNE)Two Sigma Investments LP acquired a new position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 20,629 shares of the company's stocJune 10, 2025 | marketbeat.comNeurogene Inc. (NASDAQ:NGNE) Receives Average Rating of "Moderate Buy" from BrokeragesNeurogene Inc. (NASDAQ:NGNE - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seven brokerages that are presently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendationJune 8, 2025 | marketbeat.comNeurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 6, 2025 | businesswire.comSquarepoint Ops LLC Has $398,000 Holdings in Neurogene Inc. (NASDAQ:NGNE)Squarepoint Ops LLC increased its holdings in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 250.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 17,431 shares of the company's stock after buying an additional 12,451June 6, 2025 | marketbeat.comNeurogene Reports Q1 2025 Financial Progress and UpdatesMay 31, 2025 | tipranks.comStifel maintient sa recommandation d’achat sur Neurogene avec un objectif de 46€May 29, 2025 | fr.investing.comDeutsche Bank AG Sells 181,997 Shares of Neurogene Inc. (NASDAQ:NGNE)Deutsche Bank AG cut its stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 54.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 152,371 shares of the company's stock after selling 181,997 shares during the period. Deutsche Bank AG ownedMay 23, 2025 | marketbeat.com80,000 Shares in Neurogene Inc. (NASDAQ:NGNE) Bought by Vestal Point Capital LPVestal Point Capital LP acquired a new position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 80,000 shares of the company's stock, valued at approximately $1,829,0May 21, 2025 | marketbeat.comRaiffeisen Bank International AG Makes New Investment in Neurogene Inc. (NASDAQ:NGNE)Raiffeisen Bank International AG acquired a new stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 16,000 shares of the company's stock, valuMay 20, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Invests $322,000 in Neurogene Inc. (NASDAQ:NGNE)The Manufacturers Life Insurance Company purchased a new stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 14,079 shares of the company's stock, valued at approximately $322,000. The ManufactMay 20, 2025 | marketbeat.comNeurogene (NASDAQ:NGNE) Stock Rating Lowered by Baird R WBaird R W lowered Neurogene from a "strong-buy" rating to a "hold" rating in a research report on Friday.May 19, 2025 | marketbeat.comRTW Investments LP Purchases 215,000 Shares of Neurogene Inc. (NASDAQ:NGNE)RTW Investments LP increased its position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 18.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,350,256 shares of the company's stock after buying an additionalMay 18, 2025 | marketbeat.comBaird Downgrades Neurogene (NGNE)May 16, 2025 | msn.comNeurogene Announces Evidence-Based Monitoring and Treatment Intended to Reverse Rare Hyperinflammatory Syndrome Associated with High-Dose AAVMay 16, 2025 | finance.yahoo.comStuart Cobb Sells 6,797 Shares of Neurogene Inc. (NASDAQ:NGNE) StockMay 16, 2025 | insidertrades.comOCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $748,000 Position in Neurogene Inc. (NASDAQ:NGNE)OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 270.8% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 32,734 shares of the company's stock after purchasMay 16, 2025 | marketbeat.comNeurogene Inc. (NASDAQ:NGNE) Given Average Recommendation of "Buy" by AnalystsNeurogene Inc. (NASDAQ:NGNE - Get Free Report) has been assigned an average rating of "Buy" from the seven brokerages that are covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the compMay 16, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Sells 23,477 Shares of Neurogene Inc. (NASDAQ:NGNE)Schonfeld Strategic Advisors LLC lowered its holdings in Neurogene Inc. (NASDAQ:NGNE - Free Report) by 71.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,189 shares of the company's stock after selling 2May 16, 2025 | marketbeat.comNeurogene (NASDAQ:NGNE) Given New $45.00 Price Target at HC WainwrightHC Wainwright dropped their price objective on shares of Neurogene from $50.00 to $45.00 and set a "buy" rating on the stock in a research report on Tuesday.May 15, 2025 | marketbeat.comOctagon Capital Advisors LP Increases Stake in Neurogene Inc. (NASDAQ:NGNE)Octagon Capital Advisors LP increased its stake in Neurogene Inc. (NASDAQ:NGNE - Free Report) by 1,920.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 303,000 shares of the comMay 15, 2025 | marketbeat.comDriehaus Capital Management LLC Sells 69,422 Shares of Neurogene Inc. (NASDAQ:NGNE)Driehaus Capital Management LLC decreased its position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 67.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 32,765 shares of the company's stock after selling 6May 13, 2025 | marketbeat.comNeurogene (NASDAQ:NGNE) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPSNeurogene (NASDAQ:NGNE - Get Free Report) posted its quarterly earnings results on Friday. The company reported ($1.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.05) by ($0.03).May 13, 2025 | marketbeat.comDAFNA Capital Management LLC Has $1.18 Million Position in Neurogene Inc. (NASDAQ:NGNE)DAFNA Capital Management LLC grew its position in Neurogene Inc. (NASDAQ:NGNE - Free Report) by 562.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 51,500 shares of the company's stock after purchasing an additionalMay 10, 2025 | marketbeat.comDeerfield Management Company L.P. Series C Makes New Investment in Neurogene Inc. (NASDAQ:NGNE)Deerfield Management Company L.P. Series C acquired a new stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 448,145 shares of the company's stock, valued at apMay 10, 2025 | marketbeat.comNeurogene Reports First Quarter 2025 Financial Results and Highlights Recent UpdatesMay 9, 2025 | businesswire.comNeurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 8, 2025 | businesswire.comCasdin Capital LLC Grows Stake in Neurogene Inc. (NASDAQ:NGNE)Casdin Capital LLC lifted its stake in Neurogene Inc. (NASDAQ:NGNE - Free Report) by 146.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,295,361 shares of the company's stock after purchasing an additiMay 8, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Invests $2.82 Million in Neurogene Inc. (NASDAQ:NGNE)Price T Rowe Associates Inc. MD acquired a new stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 123,291 shares of the company's stock, valued at approximaMay 8, 2025 | marketbeat.comBaker BROS. Advisors LP Boosts Holdings in Neurogene Inc. (NASDAQ:NGNE)Baker BROS. Advisors LP grew its position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 47.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 674,450 shares of the company's stock after buying an additional 218,435 shares durinMay 6, 2025 | marketbeat.comArrowMark Colorado Holdings LLC Has $10.26 Million Stock Position in Neurogene Inc. (NASDAQ:NGNE)ArrowMark Colorado Holdings LLC grew its position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 16.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 448,601 shares of the company's stock after acquiring aMay 6, 2025 | marketbeat.comNeurogene (NGNE) Expected to Announce Earnings on FridayNeurogene (NASDAQ:NGNE) will be releasing its Q1 2025 earnings before the market opens on Friday, May 9. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-9-neurogene-inc-stock/)May 4, 2025 | marketbeat.comSamsara BioCapital LLC Acquires 449,337 Shares of Neurogene Inc. (NASDAQ:NGNE)Samsara BioCapital LLC lifted its stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 35.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,717,127 shares of the company's stock after buying an additional 449,337 sharesMay 2, 2025 | marketbeat.comNeurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare Complication of High Dose Gene Therapy at the ASGCT Annual MeetingApril 28, 2025 | businesswire.comRock Springs Capital Management LP Invests $2.18 Million in Neurogene Inc. (NASDAQ:NGNE)Rock Springs Capital Management LP bought a new position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 95,407 shares of the company's stock, valApril 23, 2025 | marketbeat.comNeurogene Inc. (NASDAQ:NGNE) Shares Bought by Walleye Capital LLCWalleye Capital LLC grew its position in Neurogene Inc. (NASDAQ:NGNE - Free Report) by 68.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 74,836 shares of the company's stock after buying an additiApril 22, 2025 | marketbeat.comNeurogene Inc. (NASDAQ:NGNE) Given Average Rating of "Buy" by BrokeragesShares of Neurogene Inc. (NASDAQ:NGNE - Get Free Report) have been given a consensus recommendation of "Buy" by the eight analysts that are presently covering the company, Marketbeat reports. Seven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating oApril 21, 2025 | marketbeat.comBMO Capital Markets Has Lowered Expectations for Neurogene (NASDAQ:NGNE) Stock PriceBMO Capital Markets dropped their target price on Neurogene from $45.00 to $16.00 and set an "outperform" rating on the stock in a research report on Monday.April 16, 2025 | marketbeat.comJPMorgan Chase & Co. Purchases 476,418 Shares of Neurogene Inc. (NASDAQ:NGNE)JPMorgan Chase & Co. grew its holdings in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 10,395.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 481,001 shares of the company's stock after purchasing an additionApril 16, 2025 | marketbeat.comNeurogene price target lowered to $16 from $45 at BMO CapitalApril 14, 2025 | markets.businessinsider.comNeurogene modifie son accord et émet des bons de souscriptionApril 14, 2025 | fr.investing.comBMO réduit l’objectif de cours de Neurogene à 16$ contre 45$, maintient SurperformanceApril 14, 2025 | fr.investing.comL’action NGNE touche son plus bas niveau sur 52 semaines à 8,35$April 7, 2025 | fr.investing.com Get Neurogene News Delivered to You Automatically Sign up to receive the latest news and ratings for NGNE and its competitors with MarketBeat's FREE daily newsletter. Email Address NGNE Media Mentions By Week NGNE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NGNE News Sentiment▼0.690.90▲Average Medical News Sentiment NGNE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NGNE Articles This Week▼103▲NGNE Articles Average Week Get Neurogene News Delivered to You Automatically Sign up to receive the latest news and ratings for NGNE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AUPH News WVE News NAGE News MLYS News RCUS News SYRE News AKBA News CVAC News ELVN News PAHC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NGNE) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhat 99% of investors are missing about Chinese AIChinese AI chatbot DeepSeek's release put the spotlight on AI and turned the tech world on its head. But 99...Weiss Ratings | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurogene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NGNE Stock Free NGNE Stock Alerts